MedPath

A clinical trial to study the analgesic effect of dexmeditomedine and midazolam with lignocaine for intravenous regional anesthesia

Phase 4
Completed
Conditions
ASA 1ASA 2
Registration Number
CTRI/2015/08/006142
Lead Sponsor
DR RAJENDRA PRASAD GOVT MEDICAL COLLEGE AND HOSPITAL
Brief Summary

This study is randomised trial ,comparing the analgesic efficacy of dexmeditomedine and midazolam when added to lignocaine for intravenous regional anesthesia.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
60
Inclusion Criteria

normal baseline ECG ASA 1 and 2.

Exclusion Criteria

patients with history of allergy to local anesthetics patients who are highly nervous and uncooperative patients wiyh crush injury and open wound on hands patients with infection and cellulitis of operative limb patients with history of epilepsy patients with peripheral arterial disease,sickle cell disease,AV malformation patients of ASA 3,4 and 5 pregnancy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
HEART RATEo min | 5 min | 10 min | 15 min | 20 min | 40 min | 60 min | 90 min
NON INVASIVE BLOOD PRESSUREo min | 5 min | 10 min | 15 min | 20 min | 40 min | 60 min | 90 min
MEAN ARTERIAL PRESSUREo min | 5 min | 10 min | 15 min | 20 min | 40 min | 60 min | 90 min
PARTIAL PRESSURE OF OXYGEN SATURATIONo min | 5 min | 10 min | 15 min | 20 min | 40 min | 60 min | 90 min
Secondary Outcome Measures
NameTimeMethod
SEDATION SCOREo min

Trial Locations

Locations (1)

Dr RPGMC

🇮🇳

Kangra, HIMACHAL PRADESH, India

Dr RPGMC
🇮🇳Kangra, HIMACHAL PRADESH, India
DR geeta choudhary
Principal investigator
8894674909
gcgeetsj0@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.